Gastrointestinal (GI)

Gastrointestinal Oncology

Cancer is one of the leading causes resulting in deaths, disorders, and disabilities, worldwide. Among all the organ cancers, gastrointestinal tract cancer follows a peculiar distribution pattern all over the world. They are responsible for more deaths than any other cancers. Also referred to as stomach cancer, these malignant gastric tumors are majorly found in people aged between 50 to 70 years. However, they are more common among male individuals.

Narayana Health provides advanced, comprehensive care for the early diagnoses and treatment of

• Colon cancer
• Pancreatic cancer
• Stomach cancer
• Liver cancer
• Neuroendocrine cancer
• Esophageal cancer

Patients can get ontologically sound surgeries for Colorectal and Liver Cancers with minimal access technique, thus ensuring faster recovery & quick return to normal life.

Our team of specialists includes radiation oncologists, surgeons, and medical oncologists who work together to develop a comprehensive treatment plan for our patients.

At Narayana Health network Hospitals, our Gastrointestinal Oncology division exclusively focuses on handling such complications. We ensure the diagnosis and treatment of gastric malignancies through foremost experts from the field. Our center offers advanced treatment facilities and expertise for a range of Gastrointestinal Cancers including Esophagectomies, Pancreatic and Gallbladder Cancer, Colon and Rectal Cancer, and Liver Resection. With an exceptional depth of knowledge, innovative research and technology, and a compassionate approach, NH gastrointestinology experts can facilitate comprehensive care and personalized evaluation for each patient.

To offer the broadest possible range of treatment options, oncologists and dedicated professionals at NH are consistently investing efforts in bringing advancements in:

• Endoscopic procedures
• Laparoscopy and other minimally invasive surgeries
• Pain management
• Interventional radiology
• Functional imaging
• Novel chemotherapy drugs
• Molecular therapies and immunotherapies
• Risk assessment, early detection, screening, and prevention methods